Compare MFC & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MFC | ELV |
|---|---|---|
| Founded | 1887 | 1944 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.1B | 86.6B |
| IPO Year | 2002 | 2001 |
| Metric | MFC | ELV |
|---|---|---|
| Price | $44.31 | $400.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 19 |
| Target Price | $52.00 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 05-13-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.40% | 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.73 |
| Revenue | N/A | ★ $199,125,000,000.00 |
| Revenue This Year | $40.66 | N/A |
| Revenue Next Year | $6.23 | $3.07 |
| P/E Ratio | ★ $16.52 | $26.51 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $29.70 | $274.89 |
| 52 Week High | $45.33 | $436.24 |
| Indicator | MFC | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 59.58 | 50.74 |
| Support Level | $41.68 | $382.77 |
| Resistance Level | $45.33 | $408.00 |
| Average True Range (ATR) | 0.76 | 9.45 |
| MACD | -0.15 | 1.38 |
| Stochastic Oscillator | 69.59 | 66.61 |
Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, asset management, and wealth management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 21% of 2025 adjusted earnings. The Asia segment operates across 12 countries and contributes around 38% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 16% of earnings. Manulife's global asset and wealth management business contributes approximately 25% of its earnings and had around CAD 1.1 trillion in assets under management and administration as of the end of 2025.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.